Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference
(World News UK)

BOSTON, Sept.19, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that Proteostasis management will present at the UK Cystic Fibrosis Conference (UKCFC) on September 26-27, 2019 at the Kia Oval in Kennington, London, England. Details for the presentation are as follows: Title: Access and the Unmet Need: Novel CFTR Modulator Combinations are Coming Presenter: Marija Zecevic, Ph.D., Chief Commercial Officer Session Title: Development of new therapies for...